Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Endovascular Aneurysm Repair Market, by Indication
1.4.2 North America Endovascular Aneurysm Repair Market, by Product
1.4.3 North America Endovascular Aneurysm Repair Market, by Site
1.4.4 North America Endovascular Aneurysm Repair Market, by Anatomy
1.4.5 North America Endovascular Aneurysm Repair Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Endovascular Aneurysm Repair Market
Chapter 4. North America Endovascular Aneurysm Repair Market by Indication
4.1 North America Abdominal Market by Country
4.2 North America Thoratic Market by Country
Chapter 5. North America Endovascular Aneurysm Repair Market by Product
5.1 North America Percutaneous Evar Market by Country
5.2 North America Fenestrated Evar Market by Country
5.3 North America Aortic Stents & Taa Graft Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Endovascular Aneurysm Repair Market by Site
6.1 North America Infrarenal Market by Country
6.2 North America Pararenal Market by Country
Chapter 7. North America Endovascular Aneurysm Repair Market by Anatomy
7.1 North America Traditional Market by Country
7.2 North America Complex Market by Country
Chapter 8. North America Endovascular Aneurysm Repair Market by Country
8.1 US Endovascular Aneurysm Repair Market
8.1.1 US Endovascular Aneurysm Repair Market by Indication
8.1.2 US Endovascular Aneurysm Repair Market by Product
8.1.3 US Endovascular Aneurysm Repair Market by Site
8.1.4 US Endovascular Aneurysm Repair Market by Anatomy
8.2 Canada Endovascular Aneurysm Repair Market
8.2.1 Canada Endovascular Aneurysm Repair Market by Indication
8.2.2 Canada Endovascular Aneurysm Repair Market by Product
8.2.3 Canada Endovascular Aneurysm Repair Market by Site
8.2.4 Canada Endovascular Aneurysm Repair Market by Anatomy
8.3 Mexico Endovascular Aneurysm Repair Market
8.3.1 Mexico Endovascular Aneurysm Repair Market by Indication
8.3.2 Mexico Endovascular Aneurysm Repair Market by Product
8.3.3 Mexico Endovascular Aneurysm Repair Market by Site
8.3.4 Mexico Endovascular Aneurysm Repair Market by Anatomy
8.4 Rest of North America Endovascular Aneurysm Repair Market
8.4.1 Rest of North America Endovascular Aneurysm Repair Market by Indication
8.4.2 Rest of North America Endovascular Aneurysm Repair Market by Product
8.4.3 Rest of North America Endovascular Aneurysm Repair Market by Site
8.4.4 Rest of North America Endovascular Aneurysm Repair Market by Anatomy
Chapter 9. Company Profiles
9.1 Endologix LLC
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Product Launches and Product Expansions:
9.1.2.2 Approvals and Trials:
9.2 Lombard Medical Limited
9.2.1 Company Overview
9.3 Cardinal Health, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Recent strategies and developments:
9.3.4.1 Approvals and Trials:
9.4 Becton, Dickinson and Company
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Medtronic PLC
9.5.1 Company overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Approvals and Trials:
9.6 Cook Medical, Inc. (Cook Group)
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Partnerships, Collaborations, and Agreements:
9.6.2.2 Approvals and Trials:
9.7 Koninklijke Philips N.V.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Acquisition and Mergers:
9.8 Terumo Corporation
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Product Launches and Product Expansions:
9.8.4.2 Acquisition and Mergers:
9.9 Abbott Laboratories
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Acquisition and Mergers:
9.10. Artivion, Inc. (JOTEC GmbH)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
Unique Offerings 